Marina Biotech Completes Dosing of Second Cohort in the Phase 1b START-FAP Clinical Trial of CEQ508
2012 Press Releases
4/19/2012
Marina Biotech Regains Intellectual Property Rights to its tkRNAi™ Technology for Agriculture and Veterinary Uses
5/8/2012
Marina Biotech Announces Worldwide Exclusive Licensing Agreement with Monsanto
5/10/2012
Marina Biotech Receives Three Notices of Allowances from the USPTO and an Intent to Grant Notice from the European Patent Office
5/21/2012
Marina Biotech and Girindus Group Announce Strategic Alliance
6/1/2012
Marina Biotech Ceases Most Day-to-Day Operations
8/3/2012
Marina Biotech Announces Worldwide Non‐Exclusive Licensing Agreement for Nucleic Acid Chemistry
8/22/2012
Marina Biotech Provides Update on Company Operations
10/11/2012
Marina Biotech, Inc. Announces Full Year 2011 Financial Results
11/29/2012
Marina Biotech Announces Worldwide Non-Exclusive Licensing Agreement with Nucleic Acid Chemistry to Tekmira Pharmaceuticals